نتائج البحث

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

• Authors : Savage, Kerry J; Horwitz, Steven M; Advani, Ranjana

Subjects: Brentuximab Vedotin; Cyclophosphamide/adverse effects; Doxorubicin/adverse effects

• Source: Savage , K J , Horwitz , S M , Advani , R , Christensen , J H , Domingo-Domenech , E , Rossi , G , Morschhauser , F , Alpdogan , O , Suh , C , Tobinai , K , Shustov , A

تفاصيل العنوان

Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.

• Authors : Casasnovas, René-Olivier; Bouabdallah, Reda; Brice, Pauline

Subjects: Bleomycin; Procarbazine; Vincristine

• Source: Journal of Clinical Oncology, 40, 1091 - 1101 (2022)

تفاصيل العنوان

Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.

• Authors : Kuruvilla, John; Armand, Philippe; Hamadani, Mehdi

Subjects: NON-Hodgkin's lymphoma; HEMATOPOIETIC stem cell transplantation; PEMBROLIZUMAB

• Source: Leukemia & Lymphoma; Jan2023, Vol. 64 Issue 1, p130-139, 10p

تفاصيل العنوان

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

• Authors : Bachy, Emmanuel; Houot, Roch; Morschhauser, Franck ...

Subjects: IMPROVED SURVIVAL; UNITED-STATES; PHASE-III

• Source: ISSN: 0390-6078.

تفاصيل العنوان

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.

• Authors : Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University, Boston, MA.; Solomon SR

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Adult

• Source: Blood [Blood] 2023 Apr 06; Vol. 141 (14), pp. 1675-1684.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

تفاصيل العنوان

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

• Authors : Decanter, Christine^1,2 ; Morschhauser, Franck^2,3; Pigny, Pascal^2,4

• Source: Reproductive BioMedicine Online (Reproductive Healthcare Limited). Feb2010, Vol. 20 Issue 2, p280-285. 6p.

تفاصيل العنوان

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.

• Authors : Kamdar M; Solomon SR ...

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Thrombocytopenia*/Thrombocytopenia*/Thrombocytopenia*/drug therapy

• Source: Lancet (London, England) [Lancet] 2022 Jun 18; Vol. 399 (10343), pp. 2294-2308.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

تفاصيل العنوان

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.

• Authors : Schenone L; Houillier C ...

Subjects: Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/drug therapy ; Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/Central Nervous System Neoplasms*/pathology ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

• Source: Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 966-974. Date of Electronic Publication: 2022 Apr 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

• Authors : Bishop MR; From the David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago (M.R.B.); Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC (M. Dickinson), Fiona Stanley Hospital, Murdoch, WA (D.P.), and the Department of Haematology, St. Vincent's Hospital Sydney, and St. Vincent's Clinical School, University of New South Wales, Sydney (N.H.) - all in Australia

Subjects: Hematopoietic Stem Cell Transplantation* ; Immunotherapy, Adoptive*; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use

• Source: The New England journal of medicine [N Engl J Med] 2022 Feb 17; Vol. 386 (7), pp. 629-639. Date of Electronic Publication: 2021 Dec 14.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.

• Authors : Nerich V; Department of Pharmacy, University Hospital, Besançon, France.; INSERM, EFS-BFC, UMR1098, University of Franche-Comté, Besançon, France.

Subjects: Hematopoietic Stem Cell Transplantation* ; Lymphoma* ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/therapy

• Source: Cancer [Cancer] 2022 Feb 01; Vol. 128 (3), pp. 519-528. Date of Electronic Publication: 2021 Oct 04.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

تفاصيل العنوان